ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE: 340 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
340
Total FAERS Reports
15 (4.4%)
Deaths Reported
51
Hospitalizations
340
As Primary/Secondary Suspect
10
Life-Threatening
3
Disabilities
Active Ingredient: ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE HYDROCHLORIDE ·
First Report: 2005 · Latest Report: 20250504
What Are the Most Common ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE Side Effects?
#1 Most Reported
Choking
46 reports (13.5%)
#2 Most Reported
Drug ineffective
35 reports (10.3%)
#3 Most Reported
Dizziness
28 reports (8.2%)
All ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Choking | 46 | 13.5% | 0 | 0 |
| Drug ineffective | 35 | 10.3% | 2 | 8 |
| Dizziness | 28 | 8.2% | 0 | 2 |
| Dyspnoea | 25 | 7.4% | 1 | 3 |
| Foreign body in throat | 20 | 5.9% | 0 | 0 |
| Nausea | 20 | 5.9% | 0 | 4 |
| Loss of consciousness | 19 | 5.6% | 0 | 1 |
| Vomiting | 18 | 5.3% | 0 | 7 |
| Overdose | 17 | 5.0% | 1 | 6 |
| Product use complaint | 16 | 4.7% | 0 | 0 |
| Somnolence | 16 | 4.7% | 0 | 4 |
| Urticaria | 16 | 4.7% | 0 | 1 |
| Diarrhoea | 15 | 4.4% | 0 | 4 |
| Hallucination | 14 | 4.1% | 0 | 0 |
| Headache | 14 | 4.1% | 0 | 2 |
| Abdominal pain upper | 13 | 3.8% | 0 | 5 |
| Drug administration error | 12 | 3.5% | 0 | 1 |
| Feeling abnormal | 11 | 3.2% | 0 | 2 |
| Oropharyngeal pain | 11 | 3.2% | 0 | 0 |
| Rash | 11 | 3.2% | 0 | 0 |
Who Reports ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE Side Effects? Age & Gender Data
Gender: 68.0% female, 32.0% male. Average age: 48.8 years. Most reports from: US. View detailed demographics →
Is ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 2 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 0 |
| 2012 | 3 | 2 | 1 |
| 2013 | 4 | 0 | 3 |
| 2014 | 16 | 1 | 4 |
| 2015 | 39 | 1 | 7 |
| 2016 | 23 | 0 | 3 |
| 2017 | 26 | 2 | 5 |
| 2018 | 16 | 0 | 2 |
| 2019 | 21 | 1 | 5 |
| 2020 | 17 | 0 | 2 |
| 2021 | 10 | 0 | 0 |
| 2022 | 16 | 1 | 2 |
| 2023 | 14 | 0 | 1 |
| 2024 | 12 | 0 | 0 |
| 2025 | 5 | 0 | 0 |
What Is ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE Used For?
| Indication | Reports |
|---|---|
| Nasopharyngitis | 115 |
| Product used for unknown indication | 101 |
| Cough | 41 |
| Hypersensitivity | 23 |
| Influenza | 23 |
| Oropharyngeal pain | 13 |
| Nasal congestion | 12 |
| Respiratory tract congestion | 8 |
| Rhinorrhoea | 7 |
| Malaise | 6 |
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs Alternatives: Which Is Safer?
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\PHENYLEPHRINE
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\DIHYDROCODEINE
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\DIPHENHYDRAMINE
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\HYDROCODONE
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN/HYDROCODONE
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\IBUPROFEN
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\METHOCARBAMOL
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\OPIUM
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\OXYCODONE
ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE vs ACETAMINOPHEN\OXYCODONE\OXYCODONE
Official FDA Label for ACETAMINOPHEN\DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE
Official prescribing information from the FDA-approved drug label.